Sort
261,768 grants matching “gene therapy”
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
$1,585,768Amato J. Giaccia · Stanford University · P01 · FY2015 · CA
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
$1,585,768Amato J. Giaccia · Stanford University · P01 · FY2016 · CA
Molecular Gene and Radiation Therapies for Cancer
$1,585,764Henry Ford Health System · P01 · FY2005 · CA
Roles of Cdk5 in neurodevelopment and neurodegeneration
$1,585,714Edward Giniger · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
A comprehensive research resource to define mechanisms underlying microbial regulation of host metabolism in pediatric obesity and obesity-targeted therapeutics
$1,585,625John F Rawls · Duke University · R24 · FY2016 · DK
Biomarkers in Cancer Diagnosis,Prognosis, and Therapeutic Outcome
$1,585,226Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Boston Area Diabetes Endocrinology Research Center
$1,585,182Joseph Avruch · Massachusetts General Hospital · P30 · FY2009 · DK
Boston Area Diabetes Endocrinology Research Center
$1,585,182Joseph Avruch · Massachusetts General Hospital · P30 · FY2008 · DK
Boston Area Diabetes Endocrinology Research Center
$1,585,182Joseph Avruch · Massachusetts General Hospital · P30 · FY2007 · DK
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
$1,585,167Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2024 · AG
Papillomavirus Virion Proteins and Vaccines
$1,585,014John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Epidemiology and Natural History of Cancer-Associated Viruses
$1,584,716Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
$1,584,706Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2023 · AG
Improving Retroviral Vectors for Gene Delivery
$1,584,584University Of Southern California · P01 · FY2003 · CA
Project 2
$1,584,450Alan D Frankel · University Of California, San Francisco · U54 · FY2022 · AI
TUMOR HYPOXIA--MOLECULAR STUDIES &CLINICAL EXPLOITATION
$1,584,418Stanford University · P01 · FY2000 · CA
Genetic susceptibility to unrelated donor stem cell transplant-related mortality
$1,584,230Theresa E Hahn · Roswell Park Cancer Institute Corp · R01 · FY2010 · HL
Development of a human hepatocyte predictive pharmacology and toxicology system.
$1,584,146Brian Robert Wamhoff · Hemoshear Therapeutics, Llc · R44 · FY2013 · DK
Characterization Of Novel Chemokine Receptors In Lymphocytes
$1,584,105Joshua M Farber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Anti-Fibrotic Therapy for Scleroderma/SSc
$1,584,102Latha Paka · Angion Biomedica Corporation · R44 · FY2014 · AR
Immuno-Prophylaxis-Therapy &Diagnosis of Tularemia
$1,584,061Boston Medical Center · U19 · FY2003 · AI
Functional Analysis of Novel Genes in Eye Development and Vision
$1,584,030Graeme J Wistow · National Eye Institute · ZIA · FY2025 · EY
INTERACTING FACTORS IN HEMATOPOIESIS AND LEUKEMIA
$1,583,949Daniel G Tenen · Beth Israel Deaconess Medical Center · P01 · FY2007 · CA
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
$1,583,667Katherine N Cahill · Vanderbilt University Medical Center · U01 · FY2024 · AI
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
$1,583,667Katherine N Cahill · Vanderbilt University Medical Center · U01 · FY2025 · AI